Arvinas, Inc. (ARVN)
NASDAQ·Healthcare·Biotechnology
$7.58
+2.29%
Mkt Cap $489.07M
Analyst Ratings
Buy
10
Hold
1
Sell
0
Price Target (36 analysts)
$14.75
Range $10.00 – $20.00
Implied Upside
+94.6%
Consensus $14.75 vs current $7.58
NASDAQ·Healthcare·Biotechnology
$7.58
+2.29%
Mkt Cap $489.07M
Buy
10
Hold
1
Sell
0
Price Target (36 analysts)
$14.75
Range $10.00 – $20.00
+94.6%
Consensus $14.75 vs current $7.58